Duocard Tablet 5 mg contains Cilnidipine, a long-acting calcium channel blocker (CCB) used for the treatment of hypertension (high blood pressure). This oral tablet formulation is designed for precise dose management, making it suitable for patients who require lower initial doses or careful titration of antihypertensive therapy.
Cilnidipine is a dual L-type and N-type calcium channel blocker, providing effective blood pressure reduction with minimal reflex tachycardia. By selectively relaxing vascular smooth muscles and inhibiting sympathetic nerve activity, Duocard Tablet helps improve blood flow, reduce cardiac workload, and protect end organs such as the heart and kidneys.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Cilnidipine: 5 mg per tablet
Duocard Tablet 5 mg is indicated for:
Essential hypertension in adults to lower elevated blood pressure and prevent cardiovascular complications
Patients requiring dose titration due to sensitivity or risk of hypotension
Hypertensive patients with renal involvement to maintain kidney function
Management of angina pectoris associated with high blood pressure
As part of combination therapy with other antihypertensive agents for improved control
Cilnidipine works through a dual mechanism to control blood pressure:
L-type calcium channel blockade: Relaxes arterial smooth muscles, decreasing peripheral resistance and reducing blood pressure.
N-type calcium channel blockade: Reduces sympathetic nerve activity, minimizing reflex tachycardia and improving renal perfusion.
End-organ protection: Supports cardiovascular and renal health by reducing vascular stress and maintaining adequate blood flow.
This dual action ensures effective and well-tolerated blood pressure control, even in sensitive patients or those requiring careful titration.
Route: Oral
Dosage: As prescribed by a registered physician
The usual starting dose is 5 mg once daily, which may be adjusted depending on blood pressure response and patient tolerance. Tablets should be taken at the same time every day, with or without food, for consistent blood levels. Dose modifications may be required for patients with hepatic or renal impairment. Regular blood pressure monitoring is recommended to ensure therapeutic efficacy and safety.
Effectively reduces high blood pressure and cardiovascular risk
Minimizes reflex tachycardia compared to conventional calcium channel blockers
Dual L-type and N-type action supports vascular and renal protection
Provides safe dose titration for sensitive patients or those starting therapy
Convenient once-daily oral dosing for improved adherence
Well-tolerated for long-term hypertension management
Use only under medical supervision
Contraindicated in patients with severe hypotension, cardiogenic shock, or hypersensitivity to Cilnidipine
Exercise caution in patients with heart failure, liver disease, or significant cardiac conditions
Monitor blood pressure and heart rate during therapy
Report side effects such as dizziness, headache, flushing, or palpitations
Avoid abrupt discontinuation to prevent rebound hypertension
Store below 30°C in a dry place
Protect from light and moisture
Keep out of reach of children
Calcium Channel Blocker / Antihypertensive.
Login Or Registerto submit your questions to seller
No none asked to seller yet